Amphastar Pharmaceuticals (original) (raw)
Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products. One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around 20to20 to 20to40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally.
| Property | Value |
|---|---|
| dbo:abstract | Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products. One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around 20to20 to 20to40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally. In March 2018, the company won a patent infringement lawsuit brought against it by Momenta Pharmaceuticals and Sandoz Inc in an ongoing antitrust case. (en) |
| dbo:assets | 6.715E8 (dbd:usDollar) |
| dbo:country | dbr:United_States |
| dbo:equity | 4.455E8 (dbd:usDollar) |
| dbo:location | dbr:Rancho_Cucamonga,_California |
| dbo:netIncome | 6.21E7 (dbd:usDollar) |
| dbo:numberOfEmployees | 1761 (xsd:nonNegativeInteger) |
| dbo:operatingIncome | 7.17E7 (dbd:usDollar) |
| dbo:revenue | 4.378E8 (dbd:usDollar) |
| dbo:type | dbr:Public_company |
| dbo:wikiPageExternalLink | http://www.amphastar.com/ https://www.amphastar.com/%7CAmphastar.com |
| dbo:wikiPageID | 48985275 (xsd:integer) |
| dbo:wikiPageLength | 3253 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1077498171 (xsd:integer) |
| dbo:wikiPageWikiLink | dbr:Sandoz dbr:Public_company dbr:Nasal_administration dbr:Naloxone dbr:Opioid_epidemic dbr:List_of_S&P_600_companies dbc:Health_care_companies_based_in_California dbc:Pharmaceutical_companies_of_the_United_States dbr:Rancho_Cucamonga,_California dbr:S&P_600 |
| dbp:assets | (en) 6.715E8 (dbd:usDollar) |
| dbp:bloomberg | AMPH:US (en) |
| dbp:equity | (en) 4.455E8 (dbd:usDollar) |
| dbp:google | AMPH (en) |
| dbp:homepage | https://www.amphastar.com/%7CAmphastar.com |
| dbp:location | Rancho Cucamonga, California, United States (en) |
| dbp:name | Amphstar Pharmaceuticals, Inc. (en) |
| dbp:netIncome | (en) 6.21E7 (dbd:usDollar) |
| dbp:numEmployees | 1761 (xsd:integer) |
| dbp:operatingIncome | (en) 7.17E7 (dbd:usDollar) |
| dbp:revenue | (en) 4.378E8 (dbd:usDollar) |
| dbp:secCik | AMPH (en) |
| dbp:symbol | AMPH (en) |
| dbp:type | dbr:Public_company |
| dbp:wikiPageUsesTemplate | dbt:Decrease dbt:Increase dbt:Infobox_company dbt:Reflist dbt:Short_description dbt:Small dbt:Ubl dbt:Finance_links dbt:US-company-stub |
| dbp:yahoo | AMPH (en) |
| dct:subject | dbc:Health_care_companies_based_in_California dbc:Pharmaceutical_companies_of_the_United_States |
| rdf:type | owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 dbo:Organisation |
| rdfs:comment | Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures, and sells inhalation and intranasal products. One of its products is naloxone, an injectable generic drug that treats opioid overdose, and the company was criticized when it doubled the price of the drug from around 20to20 to 20to40 in 2015 during the opioid epidemic. In February 2017, the FDA rejected the company's application to market a device that delivers naloxone intranasally. (en) |
| rdfs:label | Amphastar Pharmaceuticals (en) |
| owl:sameAs | yago-res:Amphastar Pharmaceuticals wikidata:Amphastar Pharmaceuticals https://global.dbpedia.org/id/268Ke |
| prov:wasDerivedFrom | wikipedia-en:Amphastar_Pharmaceuticals?oldid=1077498171&ns=0 |
| foaf:homepage | https://www.amphastar.com/%7CAmphastar.com |
| foaf:isPrimaryTopicOf | wikipedia-en:Amphastar_Pharmaceuticals |
| foaf:name | Amphstar Pharmaceuticals, Inc. (en) |
| is dbo:wikiPageWikiLink of | dbr:Adrenocorticotropic_hormone_(medication) dbr:Eric_Lesser dbr:List_of_S&P_600_companies dbr:Rancho_Cucamonga,_California |
| is foaf:primaryTopic of | wikipedia-en:Amphastar_Pharmaceuticals |